Sen. Paul Leads Effort To Halt FDA’s LDT Final Rule

 
• By Elizabeth Orr
  
Sen. Rand Paul (R-KY) speaks in 2015.
• Source: Shutterstock
Medtech Insight Podcast

Keep up with the top medtech business and regulatory news.

Medtech Insight brings you interviews and analysis, on the go.

SpotifyApple PodcastsWebsite

More from Legislation

More from Policy & Regulation